COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica No evidence of an increased risk for cardiac complications following mRNA COVID-...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Letter to the Editor
No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
No hay evidencia de un mayor riesgo de complicaciones cardíacas después de las vacunas de ARNm COVID-19
Paulo Ricardo Martins-Filhoa,b,
Corresponding author
prmartinsfh@gmail.com

Corresponding author.
, Antônio Carlos Sobral Sousab,c
a Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, SE, Brazil
b Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, SE, Brazil
c Division of Cardiology, University Hospital, Federal University of Sergipe, Aracaju, SE, Brazil
Read
277
Times
was read the article
39
Total PDF
238
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2022.09.001
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 14 3 17
2024 March 31 5 36
2024 February 23 3 26
2024 January 23 0 23
2023 December 18 3 21
2023 November 17 2 19
2023 October 39 3 42
2023 September 24 1 25
2023 August 14 2 16
2023 July 12 3 15
2023 May 4 2 6
2023 March 2 2 4
2023 January 17 6 23
2022 November 0 4 4
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos